We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
+15.23%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+679.66%
AUM
$9.06B
AUM Growth
+$842M
Cap. Flow
-$183M
Cap. Flow %
-2.02%
Top 10 Hldgs %
24.16%
Holding
331
New
23
Increased
115
Reduced
72
Closed
23

Top Buys

Rank Stock Value
1
MMSI icon
Merit Medical Systems
MMSI
+$43.7M
2
ALGN icon
Align Technology
ALGN
+$36.6M
3
STE icon
Steris
STE
+$32.7M
4
DOCS icon
Doximity
DOCS
+$32.4M
5
TRMB icon
Trimble
TRMB
+$32M

Sector Composition

Rank Sector Weight
1 Healthcare 26.48%
2 Technology 23.61%
3 Industrials 15.35%
4 Consumer Discretionary 14.47%
5 Communication Services 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANGI icon
126
Angi Inc
ANGI
$196M
$12.7M 0.14%
510,214
+121,750
+31% +$2.49M
TTGT icon
127
TechTarget
TTGT
$278M
$12.7M 0.14%
363,418
-66,126
-15% -$1.96M
LHX icon
128
L3Harris
LHX
$53.4B
$12.6M 0.14%
60,000
+10,000
+20% +$1.88M
KNSA icon
129
Kiniksa Pharmaceuticals
KNSA
$5.93B
$12.5M 0.14%
714,879
-45,474
-6% -$747K
OWL icon
130
Blue Owl Capital
OWL
$18.5B
$12.4M 0.14%
829,775
-15,900
-2% -$214K
CCCC icon
131
C4 Therapeutics
CCCC
$412M
$12.1M 0.13%
2,137,381
-239,425
-10% -$546K
ONT
132
Onterris Inc
ONT
$580M
$11.9M 0.13%
371,600
+91,842
+33% +$2.64M
JBTM
133
JBT Marel
JBTM
$6.39B
$11.6M 0.13%
117,075
-402,973
-77% -$41.8M
GPCR icon
134
Structure Therapeutics
GPCR
$3.78B
$11.4M 0.13%
278,732
+228,732
+457% +$13.1M
NPKI
135
NPK International
NPKI
$1.14B
$11.3M 0.12%
1,700,243
+645,955
+61% +$4.5M
WD icon
136
Walker & Dunlop
WD
$1.53B
$11.1M 0.12%
100,000
BWXT icon
137
BWX Technologies
BWXT
$15.6B
$11M 0.12%
143,223
+19,000
+15% +$1.46M
RAMP icon
138
LiveRamp
RAMP
$2.3B
$10.8M 0.12%
285,314
+45,000
+19% +$1.45M
ATMU icon
139
Atmus Filtration Technologies
ATMU
$4.18B
$10.8M 0.12%
459,776
-131,221
-22% -$2.81M
APO icon
140
Apollo Global Management
APO
$73.4B
$10.7M 0.12%
114,569
-2,800
-2% -$247K
SP
141
DELISTED
SP Plus Corporation
SP
$10.5M 0.12%
205,569
-151,626
-42% -$7.6M
TCBI icon
142
Texas Capital Bancshares
TCBI
$4.32B
$10.3M 0.11%
160,000
NGNE icon
143
Neurogene
NGNE
$712M
$10.2M 0.11%
+525,529
New +$7.53M
SILK
144
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$10.1M 0.11%
823,130
+254,378
+45% +$2.39M
ALE
145
DELISTED
Allete
ALE
$9.97M 0.11%
163,000
NOMD icon
146
Nomad Foods
NOMD
$1.68B
$9.85M 0.11%
580,867
CLX icon
147
Clorox
CLX
$12.7B
$9.84M 0.11%
+69,000
New +$9.2M
SEAT icon
148
Vivid Seats
SEAT
$85.4M
$9.65M 0.11%
76,325
+32,010
+72% +$4.38M
KNX icon
149
Knight Transportation
KNX
$11.4B
$9.64M 0.11%
167,195
+56
+0% +$2.93K
SII
150
Sprott
SII
$3.03B
$9.4M 0.1%
276,945
+18,552
+7% +$574K

Similar funds

ArrowMark Colorado Holdings's Q4 2023 Portfolio in Review

As of Q4 2023, ArrowMark Colorado Holdings held 331 positions worth $9.06B, up 10% from $8.22B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

ArrowMark Colorado Holdings's Q4 2023 filing shows 23 new, 115 increased, 72 reduced and 23 closed positions. Its largest new stake was Elastic: 310,882 shares worth $35M. The largest sale was Henry Schein, an estimated $93.7M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • ArrowMark Colorado Holdings's largest Q4 2023 buy was Elastic: 310,882 shares worth $35M.
  • ArrowMark Colorado Holdings added most to Merit Medical Systems in Q4 2023, an estimated $43.7M increase.
  • ArrowMark Colorado Holdings's biggest Q4 2023 reduction was Henry Schein, cutting an estimated $93.7M.
  • ArrowMark Colorado Holdings fully exited Tennant Co in Q4 2023, selling an estimated $73.2M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 24% of its $9.06B portfolio in Q4 2023.
  • ArrowMark Colorado Holdings opened 23 new positions and closed 23 in Q4 2023.
  • ArrowMark Colorado Holdings's portfolio value rose 10% quarter-over-quarter to $9.06B.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.